Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Range Biotechnologies has developed a proprietary translational proteomics platform that enables accurate and scalable quantification of multiple proteins across many samples simultaneously. This technology aims to address bottlenecks in multiplexing, dynamic range, and throughput within the field of proteomics. The company’s approach supports new paradigms in precision medicine by enabling better diagnostics, faster drug development processes, improved pharmacodynamic analyses during clinical trials, and comprehensive health screening. As of 2024–2025 there are no reported clinical results from therapeutic programs since the company focuses on enabling technologies rather than developing drugs directly
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Range Biotechnologies.